For research use only. Not for therapeutic Use.
m-PEG2-O-Ph-NH2 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].
Catalog Number | I044721 |
CAS Number | 65673-48-5 |
Synonyms | 4-[2-(2-methoxyethoxy)ethoxy]aniline |
Molecular Formula | C11H17NO3 |
Purity | ≥95% |
InChI | InChI=1S/C11H17NO3/c1-13-6-7-14-8-9-15-11-4-2-10(12)3-5-11/h2-5H,6-9,12H2,1H3 |
InChIKey | IWXQVPLYQQTJTR-UHFFFAOYSA-N |
SMILES | COCCOCCOC1=CC=C(C=C1)N |
Reference | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |